Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06269770

Tapentadol vs Tramadol in Total Knee Arthroplasty

Multimodal Analgesia in TKA. The Role of Tapentadol

Status
Recruiting
Phase
Phase 4
Study type
Interventional
Enrollment
96 (estimated)
Sponsor
University of Thessaly · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Compare the effectiveness of tapentadol and tramadol as part of a multimodal analgesia treatment for Total Knee Replacement (TKR).

Detailed description

As the population ages and becomes more active, the demand for TKR surgery is expected to increase. However, the treatment of TKR pain remains a challenge. Postoperative pain is associated with longer hospital stays, lower satisfaction, increased opioid consumption, and transition to chronic pain. In TKR, the risk of chronic pain can be as high as 20%. A suggested method of anesthesia and pain relief is the use of spinal anesthesia along with multimodal analgesia that includes an adductor canal block. In our hospital, the multimodal analgesia protocol consists of intraoperative sedation with dexmedetomidine, a low dose of ketamine, paracetamol, NSAIDs, and magnesium. Dexamethasone and droperidol are preferred as antiemetics as they can improve the analgesic outcome. To minimize the use of opioids, the administration of tramadol used to be the standard of care. Tapentadol is an opioid that can be equally effective in the treatment of postoperative pain and reduces the incidence of chronic pain after TKR.

Conditions

Interventions

TypeNameDescription
DRUGTapentadolAdd tapentadol, for effective pain management in a multimodal setting during TKR.
DRUGTramadolAdd tramadol, for effective pain management in a multimodal setting during TKR.

Timeline

Start date
2023-05-01
Primary completion
2025-05-01
Completion
2025-06-01
First posted
2024-02-21
Last updated
2024-05-14

Locations

1 site across 1 country: Greece

Source: ClinicalTrials.gov record NCT06269770. Inclusion in this directory is not an endorsement.